Bengaluru: Danish obesity-drug developer Zealand Pharma has partnered with US biotechnology company Generate Biomedicines to develop protein-based treatments for obesity and other metabolic diseases...
Summary as published by Business Medical Dialogues.
Read the full story
The complete article is on Business Medical Dialogues's website.
Related stories
Molecular & Cell BiologyThe Hindu
Whey protein prices soar in India: Why your daily scoop is getting expensive
Whey isolate prices have jumped from ₹2,200 to ₹3,400 per kg before GST and add-ons, as surging global demand, limited domestic production and import dependence drive up costs. As whey protein supplements get more expensive in India, what are the alternatives? Plant-based alternatives, fish or more tofu?
- Immunology & Vaccines
Pharma Biz
Calluna Pharma completes dosing in phase 2 AURORA study of CAL101 in idiopathic pulmonary fibrosis
Calluna Pharma AS (Calluna), a clinical─stage biotechnology company pioneering first─in─class antibodies for inflammatory and fibrotic diseases, announced completion of dosing in the phase 2 AURORA study of
Immunology & VaccinesLatestly
WHO Recommends Routine HPV Jabs for Girls As Young as 4
WHO vaccine advisory panel SAGE recommended Tuesday that countries consider routine HPV vaccination for girls as young as four if it improves lagging uptake, as global coverage sits at 33 percent against a 90 percent target. Experts affirmed a single-dose regimen for girls aged 9 to 14 while endorsing expanded catch-up doses to combat cervical cancer globally.
Immunology & VaccinesBusiness Medical Dialogues
BioNTech's Experimental Cancer Therapy Fails Key Trial Goal
Bengaluru: BioNTech said on Tuesday its experimental mRNA cancer immunotherapy failed to meet the first main goal of a mid-to-late-stage trial in patients with head and neck cancer.US-listed shares of...